Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease.

L A Maier1, M V Raynolds, D A Young

  • 1Department of Medicine, National Jewish Medical and Research Center, Denver, CO, USA. MaierL@njc.org

American Journal of Respiratory and Critical Care Medicine
|April 8, 1999
PubMed
Summary

The angiotensin converting enzyme (ACE) genotype was not linked to chronic beryllium disease (CBD) risk or severity. However, ACE genotype correlated with serum ACE activity and may influence immune responses to beryllium exposure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of summary measures of core body temperature in heat-related health outcome regression models.

International journal of biometeorology·2025
Same author

Highly efficient CRISPR-Cas9-mediated editing identifies novel mechanosensitive microRNA-140 targets in primary human articular chondrocytes.

Osteoarthritis and cartilage·2022
Same author

Osteoarthritis year in review: genetics, genomics, epigenetics.

Osteoarthritis and cartilage·2021
Same author

TimiRGeN: R/Bioconductor package for time series microRNA-mRNA integration and analysis.

Bioinformatics (Oxford, England)·2021
Same author

Novel protein pathways in development and progression of pulmonary sarcoidosis.

Scientific reports·2020
Same author

Identification of long non-coding RNAs expressed in knee and hip osteoarthritic cartilage.

Osteoarthritis and cartilage·2019

Area of Science:

  • Immunogenetics
  • Occupational Medicine
  • Pulmonary Medicine

Background:

  • Chronic beryllium disease (CBD) is a granulomatous lung disease caused by beryllium exposure.
  • The angiotensin converting enzyme (ACE) gene polymorphism has been implicated in various immune-mediated diseases.
  • Understanding genetic factors influencing CBD susceptibility and progression is crucial for disease management.

Purpose of the Study:

  • To investigate the association between ACE genotype and the risk of developing CBD.
  • To determine if ACE genotype influences disease severity in individuals with CBD.
  • To explore the relationship between ACE genotype, serum ACE activity, and immune responses to beryllium.

Main Methods:

  • A case-control study involving 50 CBD patients and two control groups (50 beryllium-exposed workers, 50 non-exposed workers).

Related Experiment Videos

  • Genotyping for ACE insertion (I) and deletion (D) alleles and DD genotype.
  • Measurement of serum ACE activity and evaluation of beryllium lymphocyte proliferation test (BeLPT), bronchoalveolar lavage (BAL) findings, chest radiography, pulmonary function tests, and exercise physiology.

    • Main Results:

    • No statistically significant differences in ACE allele or genotype frequencies were observed between CBD cases and control groups.
    • Serum ACE activity was significantly higher in individuals with the DD genotype (p = 0.005).
    • No significant associations were found between ACE genotype and CBD disease severity markers, although a trend towards shorter exposure duration and weaker BeLPT response in DD cases was noted.

    Conclusions:

    • The ACE genotype does not appear to be a major determinant of CBD risk or disease severity.
    • ACE genotype is associated with serum ACE activity and may play a role in the immune response to beryllium, potentially influencing disease progression.
    • Further research is warranted to elucidate the precise role of ACE in beryllium immunopathogenesis.